01—Abstract
Summary
Summary of the 8-K filed March 10, 2025. Cited figures are marked; the original filing is the authoritative source.
Elevance Health, Inc. has reaffirmed its 2025 earnings per diluted share guidance, projecting it to be between $30.40a and $31.10.
This guidance includes approximately $3.75b per diluted share attributed to net unfavorable items. Excluding these specific items, the company anticipates adjusted earnings per diluted share to range from $34.15 to $34.85. Furthermore, Elevance Health expects its total medical enrollment for the full year 2025 to align with projections previously shared in its Fourth Quarter 2024 Earnings Release.
Notably, this includes an expectation for Medicare Advantage membership to fall between 2.2 million and 2.25 million members. These reaffirmations are being communicated as company officers engage with investors over the coming weeks.
02—Key points
Key Highlights
- Reaffirms 2025 full-year shareholders' earnings guidance of $30.40 to $31.10 per diluted share.
- Guidance includes approximately $3.75 per diluted share for net unfavorable items.
- Adjusted shareholders' earnings guidance for 2025 is projected between $34.15 and $34.85 per diluted share, excluding unfavorable items.
- 2025 year-end total medical enrollment is expected to be consistent with previous guidance.
- Projects Medicare Advantage membership to be between 2.2 million and 2.25 million members for year-end 2025.
- Information is being shared during investor meetings over the next several weeks.
03—Questions
Frequently Asked Questions
What is Elevance Health's updated financial outlook for 2025?
Elevance Health has reaffirmed its 2025 shareholders' earnings guidance of $30.40 to $31.10 per diluted share. Excluding approximately $3.75 per diluted share in net unfavorable items, the company continues to expect adjusted earnings per diluted share to be in the range of $34.15 to $34.85.
What are the company's enrollment expectations for 2025?
Elevance Health anticipates that its total medical enrollment for the full year 2025 will be consistent with the guidance previously provided in its Fourth Quarter 2024 Earnings Release. This includes an expectation for Medicare Advantage membership to be between 2.2 million and 2.25 million members by year-end.
When will this information be further discussed?
Company officers will be speaking with investors over the next several weeks, during which these guidance figures and enrollment expectations will be reaffirmed.
04—Continue